Raju Prasad, Chief Financial Officer at CRISPR Therapeutics AG (CRSP), sold 54,396 shares at $60.18 ($3.3M) on 2026-01-06, disclosed to the SEC on 2026-01-08.
Open-market sale of $3.3M CRSP by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.00 | 5,004 | $300K | 9.2% |
| 2 | $60.18 | 18,933 | $1.1M | 34.8% |
| 3 | $60.18 | 18,933 | $1.1M | 34.8% |
| 4 | $60.21 | 5,763 | $347K | 10.6% |
| 5 | $60.21 | 5,763 | $347K | 10.6% |
| Total | $60.17 avg | 54,396 |
| $3.3M |
| 100% |
| Filing → |
| CRSP | SELL | 2026-01-26 | $2.1M | — | Filing → |
| CRSP | SELL | 2025-12-23 | $1.1M | — | Filing → |
| CRSP | SELL | 2025-03-24 | $181K | — | Filing → |